A COMPARATIVE STUDY OF THE INHIBITORY ACTIVITY OF CLOFIBRATE AND RELATED ANALOGS ON LIPOPROTEIN LIPASE IN VITRO = ETUDE COMPARATIVE DE L'ACTIVITE INHIBITRICE DU CLOFIBRATE ET DES ANALOGUES APPARENTES SUR LA LIPOPROTEINE LIPASE IN VITRO1973; J. MEDICIN. CHEM.; U.S.A.; DA. 1973; VOL. 16; NO 3; PP. 228-231; BIBL. 45REF.Serial Issue

Separation of fibrate-type antihyperlipidemic drugs by capillary electrophoresis and their quantitation in pharmaceuticalsKOMSTA, Lukasz; MISZTAL, Genowefa; MAJCHRZAK, Ewa et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 2, pp 408-414, issn 0731-7085, 7 p.Article

IMPIEGO CLINICO DI CLOFIBRATO DI LISINA IN CONFRONTO A CLOFIBRATO IN PAZIENTI IPERDISLIPIDEMICI = DONNEES CLINIQUES SUR LE CLOFIBRATE DE LYSINE COMPARE AU CLOFIBRATE CHEZ DES MALADES HYPERDYSLIPIDEMIQUESMAGGI GC; ITALIANO D.1978; GAZZ. MED. ITAL.; ITA; DA. 1978; VOL. 137; NO 9; PP. 399-408; ABS. ENG; BIBL. 27 REF.Article

CLOFIBRATE AND RELATED ANALOGS.WITIAK DT; NEWMAN HAI; FELLER DR et al.1977; MEDICIN. RES. SER.; U.S.A.; DA. 1977; VOL. 7; PP. (296P.); BIBL. 91 P. 1/2; ISBN 0824766814Serial Issue

Proteomic characterization of the effects of clofibrate on protein expression in rat liverLEONARD, Jean-Francois; COURCOL, Martine; GAUTIER, Jean-Charles et al.Proteomics (Weinheim. Print). 2006, Vol 6, Num 6, pp 1915-1933, issn 1615-9853, 19 p.Article

THE EFFECT OF CLOFIBRATE AND ANALOGS ON HUMAN POST-HEPARIN PLASMA LIPASES.GANESAN D; WHAYNE TF JR; WITIAK DT et al.1976; ARTERY; U.S.A.; DA. 1976; VOL. 2; NO 5; PP. 467-479; BIBL. 21 REF.Article

INDUCTION OF HEPATIC LONG-CHAIN ACYL-COA HYDROLASE BY CLOFIBRIC ACID ADMINISTRATIONKAWASHIMA Y; KATOH H; NAKAJIMA S et al.1983; BIOCHIMICA ET BIOPHYSICA ACTA; ISSN 0006-3002; NLD; DA. 1983; VOL. 752; NO 1; PP. 182-185; BIBL. 27 REF.Article

Effect of Clofibrate in Non-hemolytic Indirect Hyperbilirubinemia in Full Term NeonatesEGHBALIAN, Fatemeh; POURHOSSEIN, Abolfazl; ZANDEVAKILI, Hassan et al.Indian journal of pediatrics. 2007, Vol 74, Num 11, pp 1003-1006, issn 0019-5456, 4 p.Article

DIE LANGZEITBEHANDLUNG DER VERSCHIEDENEN HYPERLIPIDAEMIEN MIT CLOFIBRAT. = TRAITEMENT AU LONG COURS DES DIFFERENTES HYPERLIPIDEMIES PAR LE CLOFIBRATESTUDLAR M; PICHLER O; KINDLER K et al.1975; WIEN. MED. WSCHR.; OESTERR.; DA. 1975; VOL. 125; NO 50-52; PP. 746-751; BIBL. 23 REF.Article

TYPE IV HYPERLIPOPROTEINEMIA. CLOFIBRATE WITHOUT DIETARY THERAPYZELIS R; AMSTERDAM EA; SPANN JF JR et al.1972; J. AMER. MED. ASS.; U.S.A.; DA. 1972; VOL. 222; NO 3; PP. 326-328; BIBL. 12 REF.Serial Issue

EFFECTS OF CLOFIBRATE ON SOME MICROSOMAL HYDROXYLATIONS INVOLVED IN THE FORMATION AND METABOLISM OF BILE ACIDS IN RAT LIVERANGELIN B; BJORKHEM I; EINARSSON K et al.1976; BIOCHEM. J.; G.B.; DA. 1976; VOL. 156; NO 2; PP. 445-448; BIBL. 31 REF.Article

CLASSIFICATION ET THERAPEUTIQUE DES HYPERLIPIDEMIES: LES TRAITEMENTS NORMOLIPEMIANTS EN 19721972; ENTRET. DE BICHAT, THERAPEUT.; FR.; DA. 1972; PP. 23-26Serial Issue

DIE WIRKUNG VON ETOFYLLINCLOFIBRAT AUF DIE ZUSAMMENSETZUNG DER LIPOPCITEINE BEI HYPERLIPOPROTEINAEMEN TYP IIB UND IV = L'ACTION DU CLOFIBRATE D'ETOFYLLINE SUR LA COMPOSITION DES LIPOPROTEINES DANS LES HYPERLIPOPROTEINEMIES DE TYPE IIB ET IVDITSCHUNEIT HH; HUTT V; KLOER HU et al.1980; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1980; VOL. 30; 11B; PP. 2063-2067; ABS. ENG; BIBL. 17 REF.Article

PPARα agonists clofibrate and gemfibrozil inhibit cell growth, down-regulate hCG and up-regulate progesterone secretions in immortalized human trophoblast cellsHASHIMOTO, Fumie; OGUCHI, Yoshinobu; MORITA, Mieko et al.Biochemical pharmacology. 2004, Vol 68, Num 2, pp 313-321, issn 0006-2952, 9 p.Article

Effect of Clofibrate in Jaundiced Full-Term Infants : A Randomized Clinical TrialZAHEDPASHA, Yadollah; AHMADPOUR-KACHO, Mousa; HAJIAHMADI, Mahmood et al.Archives of Iranian medicine. 2007, Vol 10, Num 3, pp 349-353, 5 p.Article

Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23YUZHONG MA; SACHDEVA, Karuna; JIRONG LIU et al.Biochemical pharmacology. 2005, Vol 69, Num 9, pp 1363-1371, issn 0006-2952, 9 p.Article

Clofibrate acutely reverses saline-induced endothelial dysfunction : Role of calcium-activated potassium channelsSANKARALINGAM, Sowndramalingam; DESAI, Kaushik M; WILSON, Thomas W et al.American journal of hypertension. 2006, Vol 19, Num 11, pp 1167-1173, issn 0895-7061, 7 p.Article

SUPPRESSION OF ACUTE-PHASE SYNTHESIS OF FIBRINOGEN BY A HYPOLIPIDERNIC DRUG (CLOFIBRATE)PICKART L.1981; INT. J. TISSUE REACT.; ISSN 0250-0868; CHE; DA. 1981; VOL. 3; NO 2; PP. 65-72; BIBL. 22 REF.Article

NEW HYPOLIPIDEMIC DRUGSBENCZE WL.1978; ADV. EXPER. MED. BIOL.; USA; DA. 1978; VOL. 109; PP. 77-95; BIBL. 61 REF.Conference Paper

LE "CLOFIBRATE" ET DERIVES.VETEL JM; ADVENIER C.1977; GAZ. MED. FR.; FR.; DA. 1977; VOL. 84; NO 9; PP. 935-938 (3P.)Article

CLOFIBRATE-INDUCED LOW DENSITY LIPOPROTEIN ELEVATION THERAPEUTIC IMPLICATIONS AND TREATMENT BY COLESTIPOL RESINROSE HG; HAFT GK; JULIANO J et al.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 23; NO 3; PP. 413-427; BIBL. 1 P. 1/2Article

LE LIPAMIDE EN TANT QUE COMPOSANT DE L'ALIMENTATION PROPHYLACTIQUE LORS DE L'ACTION DU FORMOLGOLOSHCHAPOV OD; AGRANOVSKIJ MZ.1976; GIG. I SANIT.; S.S.S.R.; DA. 1976; NO 3; PP. 25-28; ABS. ANGL.; BIBL. 11 REF.Article

CLINICAL RELEVANCE OF DRUGS AFFECTING TRYPTOPHAN TRANSPORT = L'IMPORTANCE CLINIQUE DES MEDICAMENTS QUI AFFECTENT LE TRANSPORT DU TRYPTOPHANEPAOLETTI R; SIRTORI C JR; SPANO PF et al.1975; ANNU. REV. PHARMACOL.; U.S.A.; DA. 1975; VOL. 15; PP. 73-81; BIBL. 1P.Serial Issue

EFFECT OF CLOFIBRATE ON PROGRESSION OF CORONARY DISEASE: A PROSPECTIVE ANGIOGRAPHIC STUDY IN MAN = EFFET DU CLOFIBRATE SUR LA PROGRESSION DE LA CORONAROPATHIE. ETUDE ANGIOGRAPHIQUE PROSPECTIVE CHEZ L'HOMMECOHN K; SAKAI FS; LANGSTON MF JR et al.1975; AMER. HEART J.; U.S.A.; DA. 1975; VOL. 89; NO 5; PP. 591-598; BIBL. 21REF.Article

GLUCAGON SECRETION IN PRIMARY ENDOGENOUS HYPERTRIGLYCERIDEMIA BEFORE AND AFTER CLOFIBRATE TREATMENT. = SECRETION DE GLUCAGON DANS L'HYPERTRIGLYCERIDEMIE ENDOGENE PRIMAIRE AVANT ET APRES TRAITEMENT PAR CLOFIBRATETIENGO A; MUGGEO M; ASSAN R et al.1975; METABOLISM; U.S.A.; DA. 1975; VOL. 24; NO 8; PP. 901-914; BIBL. 1 P.Article